GlaxoSmithKline
GSK
#242
Rank
A$125.05 B
Marketcap
$61.35
Share price
-1.71%
Change (1 day)
-6.66%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.27

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.57. In 2022 the company made an earnings per share (EPS) of $13.49 an increase over its 2021 EPS that were of $4.76.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.27-60.93%
2022$13.49183.39%
2021$4.76-17.83%
2020$5.7921.82%
2019$4.7623.91%
2018$3.84141.48%
2017$1.5964.6%
2016$0.97-90.64%
2015$10.31178.14%
2014$3.71-48.16%
2013$7.1522.63%
2012$5.83-11.32%
2011$6.58230.25%
2010$1.99-70.98%
2009$6.866.76%
2008$6.43-15.14%
2007$7.587.82%
2006$7.0319.61%
2005$5.8818.56%
2004$4.960.36%
2003$4.9450.39%
2002$3.2831.13%
2001$2.50-25.43%
2000$3.3631.58%
1999$2.551.05%
1998$2.53-0.98%
1997$2.55-10.07%
1996$2.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.16-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.96-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.90-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.95 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.06-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.18-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.38-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA